Announcing the second annual SOSV Climate Tech 100, including 58 IndieBio alums
Post
READ MORE
Fortune
Nov 30, 2022
IndieBio’s mushroom “leather” maker MycoWorks has caught the attention of high fashion and automotive clients
4WWL TV News
Nov 30, 2022
BioAesthetics’ nipple-areolar complex grafted to breast cancer survivor for the first time
The Wall Street Journal
Nov 17, 2022
In a major win for cultivated meat, Upside Foods’ lab-grown chicken clears FDA hurdle
The Cornell Daily Sun
Nov 8, 2022
IndieBio’s Halomine and Inso Biosciences win New York state funding for disease outbreak prevention
Type
Category
MycoWorks
Fortune
Nov 30, 2022
IndieBio’s mushroom “leather” maker MycoWorks has caught the attention of high fashion and automotive clients
READ MORE
BioAesthetics
4WWL TV News
Nov 30, 2022
BioAesthetics’ nipple-areolar complex grafted to breast cancer survivor for the first time
READ MORE
Upside chicken
The Wall Street Journal
Nov 17, 2022
In a major win for cultivated meat, Upside Foods’ lab-grown chicken clears FDA hurdle
READ MORE
Halomine received $2M in funding and Inso Biosciences received $955,000. Source: Halomine
The Cornell Daily Sun
Nov 8, 2022
IndieBio’s Halomine and Inso Biosciences win New York state funding for disease outbreak prevention
READ MORE
Nourie founders Osahon Ojeaga and Dr. Mary Moore
WWD
Nov 2, 2022
IndieBio’s vegan hair extension maker Nourie to launch brand with $2.5M seed round
READ MORE
BusinessWire
Nov 1, 2022
IndieBio’s OncoPrecision closes $3.3M seed round to personalize cancer treatment with “micro avatars”
READ MORE
Yahoo
Nov 1, 2022
IndieBio’s therapeutics company Intrinsic Medicine to list on NASDAQ next year
READ MORE
Post
Oct 26, 2022
Here are videos for all the sessions at the 2022 SOSV Climate Tech Summit
READ MORE
Event Post
Oct 22, 2022
At the SOSV Climate Summit, IndieBio’s Po Bronson and three founders talk ag tech at the intersection of food security and climate change

Three ag tech founders and SOSV IndieBio Po Bronson will discuss s the future of ag tech and climate

READ MORE
Post
Oct 4, 2022
Venture’s “Rule of Five” and SyntheX’s $550 million collaboration with with Bristol Myers-Squibb
READ MORE